Inflammatory Bowel Disease Drug Market Webinar
This webinar provided a robust analysis of important drug modalities including JAK inhibitors, TNF alphas, and S1P modulators, a review of recent drug approvals, discontinuations, and trial-reported adverse events, and market insights surrounding the latest trends, factors driving growth and leading players in the IBD sectors. Watch the recording now.
Our Experts
Rachel Hourigan
House Speaker
Research Analyst
Beacon
Joseph Moss
House Speaker
Senior Market Analyst
Hanson Wade Intelligence
Farrah Vogel-Javeri
Moderator
Scientific Liaison Analyst
Beacon
You May Also Be Interested In…
Learn More About Autoimmune
- The Most Comprehensive Way to Search the Autoimmune Drug Development Landscape: Unique search ontologies based on Autoimmune drug and trial characteristics
- Market Leading Approach to Autoimmune Preclinical & Clinical Data Curation: Manual curation of key Autoimmune research and development data points by Autoimmune research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Autoimmune company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
